Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,856
datasets available to search
ShareScore release 0.9.0
Dataset results
5,856 results for “B cells”
Study Comparing BEBT-908 Combined With R to SOC for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT06792253. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of LUCAR-20SP in Subjects With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT06313957. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Zanubrutinib in Combination With Polatuzumab Vedotin, Bendamustine and Rituximab in the Treatment of Relapsed/Refractory Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT06554600. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of the Safety, Tolerability and Pharmacokinetics of HZ-A-018 in Patients With B Cell Lymphoma
ClinicalTrials.gov study NCT04173455. IPD Sharing: NO. Countries: 1. Publications: 0.
JY231 (JY231) Injection for the Treatment of B-cell Acute Lymphoblastic Leukemia (B-ALL)
ClinicalTrials.gov study NCT06514768. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Glofitamab Plus Polatuzumab Vedotin and Zuberitamab in Patients With Newly Diagnosed Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT07231250. IPD Sharing: Not stated. Countries: 1. Publications: 0.
QUILT-3.061: CD19 t-haNK in Subjects With Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT04052061. IPD Sharing: NO. Countries: 1. Publications: 0.
Production of Clinical-grade Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory B-cell Malignancies
ClinicalTrials.gov study NCT03624686. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Sub Populations of Immune Cells in Influenza A and B Patients
ClinicalTrials.gov study NCT03366402. IPD Sharing: NO. Countries: 1. Publications: 0.
The LVIVO-TaVec100 Product in the Treatment of Relapsed/Refractory B-cell Malignancies
ClinicalTrials.gov study NCT07002112. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase 2 Trial of Lisocabtagene Maraleucel for Minimal Residual Disease in Patients With Large B-cell Lymphoma
ClinicalTrials.gov study NCT07316010. IPD Sharing: Not stated. Countries: 1. Publications: 0.
JS203 Combination Regimens in B-Cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT07081022. IPD Sharing: NO. Countries: 1. Publications: 0.
Study to Evaluate Adverse Events, Change in Disease Activity, and How Oral ABBV-101 Moves Through the Body in Adult Participants With B-Cell Malignancies
ClinicalTrials.gov study NCT05753501. IPD Sharing: NO. Countries: 9. Publications: 0.
Study of Ofatumomab in Combination With ICE-chemotherapy in Patients With Diffuse Large B-cell Lymphoma (DLBCL)
ClinicalTrials.gov study NCT02412267. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase I Study of GNKG168 in Patient With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia (B-CLL)
ClinicalTrials.gov study NCT01035216. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase 1/2 Study of CD19 Chimeric Antigen Receptor T-cell (CD19 CAR-T; PL001) for Relapsed or Refractory B-cell Lymphoma
ClinicalTrials.gov study NCT05326243. IPD Sharing: NO. Countries: 1. Publications: 0.
CD19 Chimeric Antigen Receptor (CAR) T Cells for Adults With Recurrent or Refractory B Cell Malignancies
ClinicalTrials.gov study NCT04214886. IPD Sharing: NO. Countries: 1. Publications: 0.
A Trial of Polatuzumab Vedotin, Obinutuzumab and Glofitamab As a Peri-CAR-T Cell Treatment Strategy in Large B-cell Lymphoma
ClinicalTrials.gov study NCT06071871. IPD Sharing: NO. Countries: 1. Publications: 0.
Interaction Study of Ibrutinib and Cytochrome P450 (CYP) 3A Inhibitors in Participants With B-cell Malignancy
ClinicalTrials.gov study NCT02381080. IPD Sharing: Not stated. Countries: 3. Publications: 0.
A Study of Subcutaneous Blinatumomab in Children With R/R and and MRD+ B-Cell Precursor Acute Lymphoblastic Leukemia
ClinicalTrials.gov study NCT07134088. IPD Sharing: YES. Countries: 2. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.